Dr. Reddy's Laboratories Ltd. logo

RDY

Dr. Reddy's Laboratories Ltd.

$69.53

Earnings Summary

Revenue
$70830Mn
Net Profits
$13070Mn
Net Profit Margins
18.45%
PE Ratio
17.38

Highlights

Revenue:

Dr. Reddy's Laboratories Ltd.’s revenue jumped 12.48% since last year same period to $70830Mn in the Q1 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -1.83% fall in its revenue since last 3-months.

Net Profits:

Dr. Reddy's Laboratories Ltd.’s net profit jumped 36.26% since last year same period to $13070Mn in the Q1 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -5.21% fall in its net profits since last 3-months.

Net Profit Margins:

Dr. Reddy's Laboratories Ltd.’s net profit margin jumped 21.14% since last year same period to 18.45% in the Q1 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -3.45% fall in its net profit margins since last 3-months.

PE Ratio:

Dr. Reddy's Laboratories Ltd.’s price-to-earnings ratio after this Q1 2024 earnings stands at 17.38.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Dr. Reddy's Laboratories Ltd. post its latest quarter earnings

EPS Estimate Current Quarter
0.91
EPS Estimate Current Year
0.91

Highlights

EPS Estimate Current Quarter:

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 0.91 - a -98.67% fall from last quarter’s estimates.

EPS Estimate Current Year:

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 0.91.

Key Ratios

Key ratios of the Dr. Reddy's Laboratories Ltd. post its Q1 2024 earnings

Earning Per Share (EPS)
78.35
Return on Assets (ROA)
0.12
Return on Equity (ROE)
0.22

Highlights

Earning Per Share (EPS):

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) jumped 11092.86% since last year same period to 78.35 in the Q1 2024. This indicates that the Dr. Reddy's Laboratories Ltd. has generated 11092.86% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Dr. Reddy's Laboratories Ltd.’s return on assets (ROA) stands at 0.12.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) stands at 0.22.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-03-31
68.45
78.35
14.46%